z-logo
open-access-imgOpen Access
Renal Intercalated Cells Sense and Mediate Inflammation via the P2Y14 Receptor
Author(s) -
Anie Azroyan,
Virna CortezRetamozo,
Richard Bouley,
Rachel Liberman,
Ye Chun Ruan,
Evgeny Kiselev,
Kenneth A. Jacobson,
Mikäel J. Pittet,
Dennis Brown,
Sylvie Breton
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0121419
Subject(s) - inflammation , purinergic receptor , microbiology and biotechnology , kidney , chemokine , receptor , biology , chemistry , endocrinology , immunology , extracellular , biochemistry
Uncontrolled inflammation is one of the leading causes of kidney failure. Pro-inflammatory responses can occur in the absence of infection, a process called sterile inflammation. Here we show that the purinergic receptor P2Y 14 (GPR105) is specifically and highly expressed in collecting duct intercalated cells (ICs) and mediates sterile inflammation in the kidney. P2Y 14 is activated by UDP-glucose, a damage-associated molecular pattern molecule (DAMP) released by injured cells. We found that UDP-glucose increases pro-inflammatory chemokine expression in ICs as well as MDCK-C11 cells, and UDP-glucose activates the MEK1/2-ERK1/2 pathway in MDCK-C11 cells. These effects were prevented following inhibition of P2Y 14 with the small molecule PPTN. Tail vein injection of mice with UDP-glucose induced the recruitment of neutrophils to the renal medulla. This study identifies ICs as novel sensors, mediators and effectors of inflammation in the kidney via P2Y 14 .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom